People who are affected by Alzheimer's disease have a specific type of plaque, made of self-assembled molecules called beta-amyloid peptides, that build up in the brain over time. Scientists at the U.S. Department of Energy's Argonne National Laboratory, along with collaborators from the Korean Institute of Science and Technology and the Korea Advanced Institute of Science and Technology, have developed an approach to prevent plaque formation by engineering a nano-sized device that captures beta-amyloid peptides before they can self-assemble.
An official website of the United States government.